» Articles » PMID: 34571870

Current Applications and Discoveries Related to the Membrane Components of Circulating Tumor Cells and Extracellular Vesicles

Overview
Journal Cells
Publisher MDPI
Date 2021 Sep 28
PMID 34571870
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

In cancer, many analytes can be investigated through liquid biopsy. They play fundamental roles in the biological mechanisms underpinning the metastatic cascade and provide clinical information that can be monitored in real time during the natural course of cancer. Some of these analytes (circulating tumor cells and extracellular vesicles) share a key feature: the presence of a phospholipid membrane that includes proteins, lipids and possibly nucleic acids. Most cell-to-cell and cell-to-matrix interactions are modulated by the cell membrane composition. To understand cancer progression, it is essential to describe how proteins, lipids and nucleic acids in the membrane influence these interactions in cancer cells. Therefore, assessing such interactions and the phospholipid membrane composition in different liquid biopsy analytes might be important for future diagnostic and therapeutic strategies. In this review, we briefly describe some of the most important surface components of circulating tumor cells and extracellular vesicles as well as their interactions, putting an emphasis on how they are involved in the different steps of the metastatic cascade and how they can be exploited by the different liquid biopsy technologies.

Citing Articles

Liquid biopsy: paving a new avenue for cancer research.

Kurma K, Eslami-S Z, Alix-Panabieres C, Cayrefourcq L Cell Adh Migr. 2024; 18(1):1-26.

PMID: 39219215 PMC: 11370957. DOI: 10.1080/19336918.2024.2395807.


Early detection of pancreatic cancer by liquid biopsy "PANLIPSY": a french nation-wide study project.

Bardol T, Dujon A, Taly V, Dunyach-Remy C, Lavigne J, Costa-Silva B BMC Cancer. 2024; 24(1):709.

PMID: 38853244 PMC: 11163786. DOI: 10.1186/s12885-024-12463-8.


The role of extracellular vesicles in circulating tumor cell-mediated distant metastasis.

Guo S, Huang J, Li G, Chen W, Li Z, Lei J Mol Cancer. 2023; 22(1):193.

PMID: 38037077 PMC: 10688140. DOI: 10.1186/s12943-023-01909-5.


Characterization of plasma circulating small extracellular vesicles in patients with metastatic solid tumors and newly diagnosed brain metastasis.

Carretero-Gonzalez A, Hergueta-Redondo M, Sanchez-Redondo S, Ximenez-Embun P, Sanchez L, Gil E Oncoimmunology. 2022; 11(1):2067944.

PMID: 35481283 PMC: 9037466. DOI: 10.1080/2162402X.2022.2067944.


An organoid model of colorectal circulating tumor cells with stem cell features, hybrid EMT state and distinctive therapy response profile.

De Angelis M, Francescangeli F, Nicolazzo C, Signore M, Giuliani A, Colace L J Exp Clin Cancer Res. 2022; 41(1):86.

PMID: 35260172 PMC: 8903172. DOI: 10.1186/s13046-022-02263-y.

References
1.
Tie J, Kinde I, Wang Y, Wong H, Roebert J, Christie M . Circulating tumor DNA as an early marker of therapeutic response in patients with metastatic colorectal cancer. Ann Oncol. 2015; 26(8):1715-22. PMC: 4511218. DOI: 10.1093/annonc/mdv177. View

2.
Marchetti A, Del Grammastro M, Felicioni L, Malatesta S, Filice G, Centi I . Assessment of EGFR mutations in circulating tumor cell preparations from NSCLC patients by next generation sequencing: toward a real-time liquid biopsy for treatment. PLoS One. 2014; 9(8):e103883. PMC: 4138040. DOI: 10.1371/journal.pone.0103883. View

3.
Cristofanilli M, Budd G, Ellis M, Stopeck A, Matera J, Miller M . Circulating tumor cells, disease progression, and survival in metastatic breast cancer. N Engl J Med. 2004; 351(8):781-91. DOI: 10.1056/NEJMoa040766. View

4.
Aceto N, Bardia A, Miyamoto D, Donaldson M, Wittner B, Spencer J . Circulating tumor cell clusters are oligoclonal precursors of breast cancer metastasis. Cell. 2014; 158(5):1110-1122. PMC: 4149753. DOI: 10.1016/j.cell.2014.07.013. View

5.
Del Boccio P, Raimondo F, Pieragostino D, Morosi L, Cozzi G, Sacchetta P . A hyphenated microLC-Q-TOF-MS platform for exosomal lipidomics investigations: application to RCC urinary exosomes. Electrophoresis. 2012; 33(4):689-96. DOI: 10.1002/elps.201100375. View